shRNA knockdown of tmTNF-α expression enhanced IκB-α levels, blocked p65 nucleus translocation, and reduced expression of cIAP1, XIAP, and Bcl-XL in the tumor tissues (Fig. 6f). The gene discussed is BIRC2; the disease is neoplasm.